Package Leaflet: Information for the Patient
Varenicline Teva 0.5 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Varenicline Teva contains the active substance varenicline. Varenicline is a medicine used in adults to help them stop smoking.
Varenicline can help to reduce the craving for smoking and the withdrawal symptoms, such as irritability and anxiety.
Varenicline may also reduce the pleasure you get from smoking if you smoke during treatment.
Do not takeVarenicline Teva
Warnings and precautions
Tell your doctor or pharmacist before you start taking Varenicline Teva.
There have been reports of depression, suicidal thoughts and behaviour, and attempted suicide in patients taking varenicline. If you are taking varenicline and experience agitation, depressed mood, changes in behaviour that concern you or your family, or if you develop suicidal thoughts or behaviour, you should stop taking varenicline and contact your doctor immediately for evaluation of treatment.
Effects of stopping smoking
The effects of the changes in your body as a result of stopping smoking, with or without treatment with varenicline, may alter the action of other medicines. Consequently, in some cases, it may be necessary to adjust the dose of other medicines. See below for more details in “Other medicines and Varenicline Teva”.
Stopping smoking, with or without treatment, has been associated in some people with an increased risk of experiencing changes in thinking or behaviour, feeling depressed or anxious, and may be associated with worsening of a psychiatric disorder. If you have a history of psychiatric disorder, you should discuss this with your doctor.
Cardiac symptoms
There have been reports of worsening or new cases of heart or blood vessel problems (cardiovascular) mainly in people who already had cardiovascular problems. Tell your doctor if you notice any change in symptoms during treatment with varenicline. If you experience symptoms of a heart attack or stroke, seek immediate medical help.
Seizures
Tell your doctor before you start taking varenicline if you have had seizures or if you are epileptic. Some people have experienced seizures during treatment with varenicline.
Hypersensitivity reactions
Stop taking varenicline and tell your doctor immediately if you experience any of the following signs and symptoms that may indicate a serious allergic reaction: swelling of the face, lips, tongue, gums, throat, or body, or difficulty breathing, wheezing.
Skin reactions
There have been reports of potentially life-threatening skin reactions (Stevens-Johnson syndrome and erythema multiforme) with the use of varenicline. If you develop a rash or blisters or your skin peels or sheds, you should stop taking varenicline and seek immediate medical attention.
Children and adolescents
Varenicline is not recommended for use in children and adolescents under 18 years because its safety and efficacy have not been established.
Other medicines and Varenicline Teva
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In some cases, as a result of stopping smoking, with or without varenicline, it may be necessary to adjust the dose of other medicines. Examples include theophylline (a medicine for respiratory problems), warfarin (a medicine to reduce blood clotting), and insulin (a medicine for diabetes). If you are in doubt, consult your doctor or pharmacist.
If you have severe kidney disease, you should avoid taking cimetidine (a medicine for stomach problems) at the same time as varenicline, as this may increase the levels of varenicline in your blood.
Useof Varenicline Teva with other smoking cessation therapies
Consult your doctor before using varenicline in combination with other smoking cessation therapies.
TakingVarenicline Tevawith alcohol
There have been some reports of increased intoxicating effects of alcohol in patients taking varenicline. However, it is not known whether varenicline increases the effects of alcohol.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is recommended to avoid the use of varenicline during pregnancy. Consult your doctor if you are planning to become pregnant.
Although it has not been studied, varenicline may pass into human breast milk. You should consult your doctor or pharmacist before taking varenicline.
Driving and using machines
Varenicline may be associated with dizziness, somnolence, and transient loss of consciousness. You should not drive, operate complex machinery, or engage in any other activity where these effects may put yourself or others at risk until you know whether this medicine affects your ability to perform these activities.
Take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
You are more likely to stop smoking if you are motivated to do so. Your doctor or pharmacist can provide you with advice, support, and further information to help you ensure that your attempt to stop smoking is successful.
Normally, before you start your treatment with varenicline, you should decide on a date during the second week of treatment (between day 8 and day 14) when you will stop smoking. If you do not want to or cannot set a date to stop smoking within these 2 weeks, you can choose your quit date between weeks 3 and 5 after starting treatment. You should write this date on the pack as a reminder.
Varenicline Teva is available as white (0.5 mg) and light blue (1 mg) film-coated tablets. You will start with the white tablets and normally move to the light blue tablets. See the table below for the usual dosing instructions to follow from Day 1.
Week 1 | Dose |
Day 1 - 3 | From day 1 to day 3, you should take one 0.5 mg white Varenicline Teva film-coated tablet once a day. From day 1 to day 3, you should take one 0.5 mg white Varenicline Teva film-coated tablet once a day. |
Day 4 - 7 | From day 4 to day 7, you should take one 0.5 mg white Varenicline Teva film-coated tablet twice a day, once in the morning and once in the evening, approximately at the same time each day. From day 4 to day 7, you should take one 0.5 mg white Varenicline Teva film-coated tablet twice a day, once in the morning and once in the evening, approximately at the same time each day. |
Week 2 | |
Day 8 – 14 | From day 8 to day 14, you should take one 1 mg light blue Varenicline Teva film-coated tablet twice a day, once in the morning and once in the evening, approximately at the same time each day. |
Weeks 3 - 12 | |
Day 15 - End of treatment | From day 15 to the end of treatment, you should take one 1 mg light blue Varenicline Teva film-coated tablet twice a day, once in the morning and once in the evening, approximately at the same time each day. |
If you have stopped smoking after 12 weeks of treatment, your doctor may recommend an additional 12 weeks of treatment with varenicline 1 mg film-coated tablets twice a day to help you avoid relapse.
If you are not able or do not want to stop smoking immediately, you should reduce your smoking during the first 12 weeks of treatment and stop at the end of this period. You should then continue to take varenicline 1 mg film-coated tablets twice a day for another 12 weeks, making a total treatment duration of 24 weeks.
If you experience side effects that you cannot tolerate, your doctor may decide to reduce your dose temporarily or permanently to 0.5 mg twice a day.
If you have kidney problems, you should consult your doctor before taking varenicline. You may need a lower dose.
Varenicline Teva is taken by mouth.
The tablets should be swallowed whole with water or can be taken with or without food.
If you take moreVarenicline Teva than you should
If you have taken more varenicline than your doctor prescribed, contact your doctor immediately, go to the nearest hospital, or call the national Poison Information Centre, telephone 91 562 04 20, stating the medicine and the amount taken. Take the pack with you.
If you forget to take Varenicline Teva
Do not take a double dose to make up for a forgotten dose. It is important that you take varenicline regularly at the same time each day. If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose.
If you stop taking Varenicline Teva
It has been shown in clinical trials that if you take all the doses of your medicine at the right times and for the recommended treatment period, you will increase your chances of stopping smoking. Therefore, unless your doctor tells you to stop treatment, it is important to continue taking varenicline as described in the table above.
In smoking cessation therapy, the risk of relapse may be high in the period immediately after the end of treatment. Temporarily, when you stop taking varenicline, you may experience increased irritability, urge to smoke, depression, and/or sleep disturbances. Your doctor may decide to gradually reduce your dose of varenicline at the end of treatment.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stopping smoking, with or without treatment, can cause various symptoms. These may include changes in mood (such as feeling depressed, irritable, frustrated, or anxious), insomnia, difficulty concentrating, decreased heart rate, and increased appetite or weight gain.
You should be aware of the possible occurrence of serious neuropsychiatric symptoms, such as agitation, depressed mood, or changes in behaviour during an attempt to stop smoking with or without varenicline, and you should contact a doctor or pharmacist if you experience these symptoms.
Serious side effects have been reported rarely in people trying to stop smoking with varenicline: seizures, stroke, heart attack, suicidal thoughts, loss of contact with reality, and inability to think or judge clearly (psychosis), changes in thinking or behaviour (such as aggressive or abnormal behaviour). Serious skin reactions, including erythema multiforme (a type of rash) and Stevens-Johnson syndrome (a serious disease with blisters on the skin, mouth, and around the eyes and genitals), and serious allergic reactions, including angioedema (swelling of the face, mouth, or throat), have also been reported.
Very common side effects: may affect more than 1 in 10 people
Common side effects: may affect up to 1 in 10 people
Uncommon side effects: may affect up to 1 in 100 people
Rare side effects: may affect up to 1 in 1,000 people
Frequency not known
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, blister, or label after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Varenicline Teva
Each 0.5 mg film-coated tablet contains 0.5 mg of varenicline (as tartrate).
Tablet core: microcrystalline cellulose, pregelatinized starch (from corn), propyl gallate, magnesium stearate, and anhydrous citric acid.
Coating: hypromellose (E-464) and titanium dioxide (E-171).
Appearance and Container Contents of the Product
Varenicline Teva 0.5 mg film-coated tablets EFG are white, capsule-shaped, film-coated tablets engraved with "0.5" on one side.
Varenicline Teva 0.5 mg film-coated tablets EFG are available in the following presentations:
Only some pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Teva B.V.
Swensweg 5,
2031GA Haarlem,
Netherlands
Manufacturer
Delorbis Pharmaceuticals Ltd.
17 Athinon Str., Ergates Industrial Area
2643 Ergates, Lefkosia
Cyprus
or
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola, PLA 3000,
Malta
You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1ª planta
28108, Alcobendas, Madrid (Spain)
Date of the last revision of this leaflet: February 2024
Other Sources of Information
You can access detailed and updated information about this medicinal product by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/89494/P_89494.html.